Berdagang Novavax NVAX

Jual
 Beli

Novavax carta live

5m 15m 30m 1h 4h 1d 1w

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

Novavax news

2021 Mei 11, 13:20

US pre-market: selling unabated

2021 Mei 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 Mei 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Berita Terkini

Tunjukkan lebih lagi
Noah Lee 2025 Sep 25, 13:20

Xiaomi 17 Launch: Chip Strategy and Car Plans Unveiled

Liam James 2025 Sep 25, 12:20

Trump's Nobel Peace Prize Chances: Undermining International Order?

Ava Grace 2025 Sep 25, 09:20

White House Budget Office Directs Federal Agencies to Prepare for Mass Layoff Plans Amid Shutdown Fears

Liam James 2025 Sep 25, 09:20

Inflation Fears Grow: Is the US Economy Heading Towards Stagflation?

Sophia Claire 2025 Sep 25, 06:20

DoubleLine Capital Flags Concerns Over US Economic Data Quality, Turns to Alternative Sources

Liam James 2025 Sep 25, 04:20

Trump Shifts Ukraine Strategy: Pressure on Europe to Step Up

Sophia Claire 2025 Sep 25, 02:20

Trump Pledges to Arab Leaders He Won't Allow Israel to Annex West Bank

Ava Grace 2025 Sep 25, 01:20

Kremlin Dismisses Trump's Ukraine Stance Shift, Demands 'Real Information'

Maklumat

Sebaran nilai

0.07

Spread (%)

0.8424 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran ditutup

Jumaat

13:31 - 19:59

Isnin

13:31-19:59

Selasa

13:31-19:59

Rabu

13:31-19:59

Khamis

13:31-19:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

1403323136

Saham Tertunggak

162421645

Tarikh Pendapatan (Seterusnya)

2019-05-10

Hasil Div

2019-05-10

Tarikh Selepas Dividen

Kadar dividen tahunan depan

0

Hasil dividen tahunan depan

0

EPS

2.22

Ketahui lebih lanjut mengenai instrumen ini

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Instrumen Berkaitan

Aset
Jual
Beli
Perubahan (%):

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang

Berdaganglah Sekarang
Instrumen Berkaitan

latest_education_articles

Tunjukkan lebih lagi
Trustpilot